M&A Deal Summary

WuXi AppTec Acquires STA Pharmaceutical

On July 31, 2017, WuXi AppTec acquired life science company STA Pharmaceutical

Acquisition Highlights
  • This is WuXi AppTec’s 7th transaction in the Life Science sector.
  • This is WuXi AppTec’s 6th transaction in the United States.
  • This is WuXi AppTec’s 3rd transaction in California.

M&A Deal Summary
Date 2017-07-31
Target STA Pharmaceutical
Sector Life Science
Buyer(s) WuXi AppTec
Deal Type Add-on Acquisition

Target

STA Pharmaceutical

San Diego, California, United States
STA Pharmaceutical Co., Ltd. is a small molecule pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with operations in China and the United States. As a premier Contract Development and Manufacturing Organization (CDMO), STA offers our worldwide partners efficient, flexible and high-quality solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

WuXi AppTec

Shanghai, China
Category Company
Founded 2000
Sector Life Science
Employees38,134
Revenue 40.3B CNY (2023)
DESCRIPTION

WuXi AppTec is a provider of pharmaceutical, biotechnology, and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi AppTec was founded in 2000 and is based in Shanghai, China.

DEAL STATS #
Overall 10 of 15
Sector (Life Science) 7 of 11
Type (Add-on Acquisition) 10 of 13
State (California) 3 of 4
Country (United States) 6 of 9
Year (2017) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-20 HD Biosciences

Shanghai, China

HD Biosciences Co., Ltd. is a biology and preclinical service provider, its plate-based pharmacology & screening capability and AGMTM based target validation are industry leading platforms with great reputation.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-17 ResearchPoint Global

Austin, Texas, United States

ResearchPoint Global is a full-service contract clinical research organization, with coverage in more than 60 countries. As a highly nimble organization with a unique blend of an experienced team, RPG provides a full range of CRO services, including project management, site selection and management, safety and medical monitoring, clinical monitoring, data management, biostatistics, as well as medical writing, across all phases of clinical development, including multi-regional clinical trials.

Buy -
Mergr

Product

Company

Legal